Stay updated on Predictive Value Drug Sensitivity Testing Tumorspheres Clinical Trial
Sign up to get notified when there's something new on the Predictive Value Drug Sensitivity Testing Tumorspheres Clinical Trial page.

Latest updates to the Predictive Value Drug Sensitivity Testing Tumorspheres Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe record describes a completed Phase 2 study investigating drug-sensitivity-guided treatment for metastatic colorectal cancer, including its eligibility criteria, treatment options, locations, and outcome measures.SummaryDifference40%

- Check20 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0 on the ClinicalTrials.gov error page.SummaryDifference0.2%

- Check27 days agoChange DetectedA site-wide NIH notice announces a website transition and says NIH content may use “Super Intelligence” alongside “Artificial Intelligence.” The study record remains inaccessible behind a 403 error.SummaryDifference1%

- Check34 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check41 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the previous study details and layout. This indicates an access restriction or site issue preventing viewing the study record.SummaryDifference16%

Stay in the know with updates to Predictive Value Drug Sensitivity Testing Tumorspheres Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Predictive Value Drug Sensitivity Testing Tumorspheres Clinical Trial page.